BioSpace News Archive

Cincinnati Children’s Hospital Medical Center Release: Study Suggests Way to Attack Deadly, Untreatable Nerve Tumors

Genomic profiling of mostly untreatable and deadly nerve sheath tumors led scientists to test a possible therapeutic strategy that inhibited tumor growth in lab tests on human tumor cells and mouse models, according to research in the journal Cancer Cell.

February 12, 2018

·

3 min read

Business

Spring Bank to Host Conference Call to Discuss Fourth Quarter and Fiscal Year 2017 Results on Wednesday, February 21

The company will provide its 2018 development outlook at 8:30am Eastern Time on Wednesday, February 21, 2018.

February 12, 2018

·

1 min read

Pharm Country

Inovio and The Wistar Institute Receive More Than $4.6M in R&D Funding to Advance Vaccines Against Tuberculosis & Malaria

The grants were from the Bill & Melinda Gates Foundation and the (NIH.

February 12, 2018

·

7 min read

FDA

Biotricity Update for Shareholders

The Company is on schedule to bring Bioflux to market within the next quarter and has already expanded its research and development efforts to capitalize on artificial intelligence AI.

February 12, 2018

·

5 min read

Drug Development

Rexahn Reports Data From the Ongoing Phase IIa Clinical Trial of RX-3117 in Advanced Bladder Cancer at the American Society of Clinical Oncology Genitourinary Cancers (ASCO GU) 2018 Annual Meeting

The poster presentation reported interim data on the Phase 2a clinical trial of RX-3117 monotherapy for the treatment of advanced bladder cancer.

February 12, 2018

·

6 min read

Pharm Country

Actinium Pharmaceuticals Reminds Investors of Today’s Deadline to be a Shareholder of Record

To be a shareholder of record, ownership of Actinium stock must occur by market close of February 12, 2018 to account for settlement.

February 12, 2018

·

8 min read

Business

Cytokinetics Names Robert Califf, M.D., to Board of Directors

Califf is also serving as an advisor to the senior management team at Verily Life Sciences.

February 12, 2018

·

6 min read

Biotech Beach

Conatus Pharmaceuticals to Host Expert Call on Unmet Need in HCV-SVR Patients

Roth Capital Partners managing director and biotechnology research analyst Yasmeen Rahimi, Ph.D., will moderate the call and lead the Q&A session.

February 12, 2018

·

4 min read

Business

Horizon Discovery Enters into License Agreement With U.S. Immuno-Oncology Company

Horizon has licensed to the Partner a novel cell line engineering technology as well as non-exclusive rights to Horizon’s proprietary Helitron transposon gene editing technology for an undisclosed financial consideration.

February 12, 2018

·

6 min read

Business

Oncoceutics Announces Appointment of Dr. Minesh Mehta to the Board of Directors

Oncoceutics announced the appointment of Minesh Mehta, MD, FASTRO, to the company’s Board of Directors.

February 12, 2018

·

2 min read